Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?

Published:2009-04 Issue:8 Volume:103 Page:1107-1112
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Usman M. Haris U.,Notaro Lawrence A.,Nagarakanti Rangadham,Brahin Eric,Dessain Scott,Gracely Edward,Ezekowitz Michael D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. History of drugs for thrombotic disease;Mueller;Circulation,1994

2. Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients;BMJ,1994

3. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition);Albers;Chest,2008

4. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes;Eikelboom;Circulation,2006

5. Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit-risk analysis;Boysen;J Intern Med,1999

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stroke and high-risk TIA outcomes with reduction of treatment duration when treatment initiated in emergency rooms (SHORTER-study);International Journal of Stroke;2024-03-16

2. Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source;Stroke;2020-07

3. Aspirin plus clopidogrel versus aspirin mono-therapy for ischemic stroke: a meta-analysis;Scandinavian Cardiovascular Journal;2019-06-06

4. Serious hemorrhages after ischemic stroke or TIA – Incidence, mortality, and predictors;PLOS ONE;2018-04-05

5. Anemia from the perspective of the problem of chronic heart failure: pathogenesis and laboratory diagnosis;Acta Medica Leopoliensia;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3